An advisory panel on vaccines meets, carefully, in the shadow of a health secretary who has often criticized it.

Dr. David Kessler, former FDA commissioner, talked with Rachel Maddow about the devastating effects of Trump’s cuts to ...

by Timothy McQuiston, Vermont Business Magazine The Vermont Department of Health reported last week that the number of COVID-19 hospitalizations remains low, at under 5 after a spike in January.

Two-thirds of Americans report spring allergies, and about 4 in 10 say they take an allergy medication several times a week. But those medicines, while valuable, don’t exactly fix the problem. One ...

American journalist Megyn Kelly has claimed that she developed an autoimmune disorder after taking two doses of the Pfizer ...

Researchers from the Federal University of São Paulo and the Butantan Institute are working on an improved version of the ...

A new study has found that most COVID-19 treatments approved in the United States are safe and not linked to serious side ...

Mark Esser, an executive at Big Pharma firm AstraZeneca, has been named the inaugural leader of UVa's future Manning ...

The statewide testing program was spurred, in part, by Michigan's checkered history with chemical contamination.

Novavax, the little-known Maryland company that received a $1.6 billion deal from the federal government for its experimental coronavirus vaccine, announced encouraging results in two preliminary ...

World Health Organization members are finalizing plans for nations to share life-saving technology with developing countries ...

Numerous treatment options for COVID-19 have been approved by the U.S. Food and Drug Administration over the last four years, including antiviral drugs and monoclonal antibodies that suppress an ...